Clinical results from any specialized cancer center are typically very difficult to reproduce in broader multicenter trials, in part because there may be differences, whether measured or unmeasured, between those presenting at renowned centers of excellence and those who remain close to home.

FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!